Sponsored Links 
United Therptcs Free of FREEDOM
United Therapeutics Corporation (UTHR - Analyst Report), a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases. It offers products primarily in three therapeutic areas, including cardiovascular, cancer and infectious diseases.
We were rightfully bearish on United heading into the FREEDOM-C data earlier in the week. The trial failed, as we predicted it would. Oral Remodulin seems unlikely before 2012. However, thanks to a quick deal with Eli Lilly & Co. (LLY - Analyst Report), United will move into the oral PAH [pulmonary arterial hypertension] market sooner than expected with Cialis.
Therefore, with the biggest hiccup now past, and upside potentially coming next year, United Therapeutics no longer looks like a Sell. Our rating is now Hold.
Read the full analyst report on UTHR
Read the full analyst report on LLY
 |
 |
 Share |
 RSS |
 Rate Pos |
 Rate Neg |
 Comment |
|
|
||||||
Loading Stories...Related Content
Best Stocks. Best Insight. Join Now...it's FREE!
Over 550,000 investors look forward to the timely insights in our email newsletter; Zacks Profit from the Pros. In each daily issue you will find:
- Free Four Zacks #1 Rank "Strong Buy" Stocks
- Free Timely Market Commentary
- Free Wealth Management Tips
- Free Profitable Strategy Screens
- Free Bull and Bear Stocks of the Day
Zacks FREE Registration
X Close
Loading Stories...Most Popular on Zacks.com
0.66 %
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
More Zacks Links
| Market Summary | Nov 26, 2009 05:56 am ET |
Sponsored Links
[CLICK TO CLOSE X]